Vaccines

Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.

The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.

The FDA has issued guidance for sponsors of requests for EUA for COVID-19 vaccines including details on clinical trial data required to support award of EUA.

CEOs of 9 drug companies involved in COVID-19 vaccine development signed a pledge ensuring that sound science and ethics will guide the process.

The CDC estimates delivery of a record 194 to 198 million doses of influenza vaccine this year. The primary care imperative: vaccinate, vaccinate, vaccinate.

The AstraZeneca-Oxford University investigational coronavirus disease 2019 (COVID-19) vaccine candidate, has expanded into a phase 3 clinical trial.

Who needs a flu shot and when is not always straightforward. This year it's more important than ever to know what the CDC recommends. Start with 3 short scenarios.

Approximately 67% of US adults are wary about trusting Russia’s Sputnik V COVID-19 vaccine without proof, according to a new survey of >30 000 Americans.

The traditional flu shot clinic with waiting rooms full won't work this year. One practice planned its own drive-through flu vaccination clinic. Here's how.

A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.